Cargando…
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
Cancer became recently the leading cause of death in industrialized countries. Even though standard treatments achieve significant effects in growth inhibition and tumor elimination, they cause severe side effects as most of the applied drugs exhibit only minor selectivity for the malignant tissue....
Autores principales: | Hoppenz, Paul, Els-Heindl, Sylvia, Beck-Sickinger, Annette G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359416/ https://www.ncbi.nlm.nih.gov/pubmed/32733853 http://dx.doi.org/10.3389/fchem.2020.00571 |
Ejemplares similares
-
Shuttling of Peptide‐Drug Conjugates by G Protein‐Coupled Receptors Is Significantly Improved by Pulsed Application
por: Ziffert, Isabelle, et al.
Publicado: (2020) -
Automated solid-phase peptide synthesis to obtain therapeutic peptides
por: Mäde, Veronika, et al.
Publicado: (2014) -
Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging
por: Moldovan, Rareş-Petru, et al.
Publicado: (2017) -
Cyclic Derivatives of the Chemerin C-Terminus as Metabolically Stable Agonists at the Chemokine-like Receptor 1 for Cancer Treatment
por: Fischer, Tobias F., et al.
Publicado: (2021) -
Development of novel bone targeting peptide–drug conjugate of 13-aminomethyl-15-thiomatrine for osteoporosis therapy
por: Su, Jia, et al.
Publicado: (2021)